KCG
DVAX

Knight Capital Group’s Dynavax Technologies DVAX Stock Holding History

Knight Capital Group’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$41K Buy
+3,803
New +$80.1K ﹤0.01% 3086

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Knight Capital Group's DVAX Position: Q2 2013 in Review

Knight Capital Group opened a new position in Dynavax Technologies (DVAX) in Q2 2013: 3,803 shares worth $41K. The stake represents ﹤0.01% of the portfolio and ranks #3086 among its holdings.

97 funds tracked by Wall St. Rank hold DVAX as of Q2 2013.

  • Knight Capital Group held 3,803 shares of Dynavax Technologies worth $41K as of Q2 2013.
  • Dynavax Technologies was a new Knight Capital Group position in Q2 2013.
  • Dynavax Technologies made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3086 holding.
  • 97 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.